Mansoor Raza Mirza, MD
Dr. Mirza is a leading European oncologist with a strong research focus in gynecologic oncology, including non-surgical treatment of gynecologic cancers. He chairs the Health Ministry’s obligatory teaching course on non-surgical treatment of cancer for Danish doctors specializing in Clinical Oncology. He is vice president of the Danish Gynecologic Cancer Group (DGCG) and medical director of Nordic Society of Gynecologic Oncology (NSGO). Dr. Mirza is the Nordic representative in the European Network of Gynecologic Oncology Trials (ENGOT) and in the Gynecologic Cancer Inter-Group (GCIG) and serves as faculty of the European Society of Medical Oncology (ESMO). He is an active member of ESGO, IGCS, ESTRO, GOG, and ASCO. He currently serves as a director of Karyopharm Therapeutics and Metamark Genetics.